The analysis, based on Medicare data, also showed women have higher risks of complications and early mortality than men.

JenaValve Technology, Inc., developer and manufacturer of the Trilogy ® Transcatheter Heart Valve (THV) System, today announced the appointment of Dave Haan as Vice President of Clinical Affairs. Dave ...

Background Stroke remains one of the most serious complications of transcatheter aortic valve implantation (TAVI). This study ...

Why it matters: Millions live with undiagnosed valvular heart disease, which can lead to heart failure, stroke, or death if untreated. What’s causing it: Valve narrowing and calcification can result ...

NEW ORLEANS – Ochsner Health has announced that Craig Sable, MD, a pediatric cardiologist with Ochsner Children’s, has been ...

It’s going to be a busy 4 days in Paris, with 166 late-breaking studies and nearly 2,000 clinical cases to be presented.

Michael Polyviou - EVC Group Inc. Good day, and thank you for standing by. Welcome to Microbot Medical Live Conference Call and Webcast. [Operator Instructions] Please be advised that today's ...

Pooling Guangdong–Hong Kong clinical strengths to deliver an end-to-end cross-border care ecosystem spanning direct billing, ...

Statins cannot touch it. Neither can diet or exercise. Lipoprotein(a), a cholesterol-like particle hardwired into a person’s DNA, circulates at elevated levels in roughly one in five adults and raises ...

The Siegel transcatheter aortic valve replacement (TAVR) system. [Image courtesy of MiRus] Boston Scientific (NYSE:BSX) announced today that it invested $1.5 billion in transcatheter aortic valve ...

Edwards announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue.

The association between amyloidosis and aortic valve stenosis has attracted considerable international attention. However, ...